Cheryl A. Madsen
General Counsel bei VIRACTA THERAPEUTICS, INC.
Profil
Cheryl A.
Madsen is currently the Senior Vice President-Regulatory Affairs at Viracta Therapeutics, Inc. She previously worked as the Senior Director at Medivation, Inc., Vice President-Regulatory Affairs at Peloton Therapeutics, Inc., and Vice President-Regulatory Affairs at Calithera Biosciences, Inc. She obtained her undergraduate degree from the University of California, Santa Cruz.
Aktive Positionen von Cheryl A. Madsen
| Unternehmen | Position | Beginn |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | General Counsel | - |
Ehemalige bekannte Positionen von Cheryl A. Madsen
| Unternehmen | Position | Ende |
|---|---|---|
| PELOTON THERAPEUTICS, INC. | General Counsel | - |
| Medivation, Inc. /Old/ | Corporate Officer/Principal | - |
| CALITHERA BIOSCIENCES, INC. | General Counsel | - |
Ausbildung von Cheryl A. Madsen
| University of California, Santa Cruz | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
